LON:ZTF - Zotefoams Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
GBX 532 -12.00 (-2.21 %)
(As of 07/20/2018 03:10 AM ET)
Previous CloseGBX 544
Today's RangeGBX 524 - GBX 542
52-Week RangeGBX 280 - GBX 532
Volume308,965 shs
Average Volume61,457 shs
Market Capitalization£229.13 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Zotefoams logoZotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polymer foam in the United Kingdom and Eire, Continental Europe, North America, and internationally. The company operates through Polyolefins, High-Performance Products (HPP), and MuCell Extrusion LLC (MEL) segments. It offers AZOTE family of polyolefin foams under the Plastazote, Evazote, and Supazote brands; ZOTEK range of high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK F, ZOTEK N, and ZOTEK PEBA brand names. The company also provides T-FIT, an advanced insulation system designed for use in clean process manufacture in the biotechnology, pharmaceuticals, and semiconductor industries. In addition, it owns and licenses patented MuCell microcellular foams technology that is used in consumer packaging, such as flexible films, bottles, and containers, as well as other specialty areas; and sells related machinery. The company serves automotive, aerospace, packaging, industrial parts, marine, building and construction, military, and sports and leisure industries. Zotefoams plc was incorporated in 1992 and is based in Croydon, the United Kingdom.

Receive ZTF News and Ratings via Email

Sign-up to receive the latest news and ratings for ZTF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange LON
Industry Specialty Chemicals
Sub-IndustryN/A
SectorBasic Materials
SymbolLON:ZTF
CUSIPN/A
Phone+44-20-86641600

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins6.73%
Return on Equity8.12%
Return on Assets4.90%

Miscellaneous

EmployeesN/A
Outstanding Shares44,410,000
Market Cap£229.13

Zotefoams (LON:ZTF) Frequently Asked Questions

What is Zotefoams' stock symbol?

Zotefoams trades on the London Stock Exchange (LON) under the ticker symbol "ZTF."

How often does Zotefoams pay dividends? What is the dividend yield for Zotefoams?

Zotefoams declared a dividend on Tuesday, March 13th. Investors of record on Thursday, April 19th will be given a dividend of GBX 4.02 per share on Thursday, May 24th. This represents a yield of 0.76%. The ex-dividend date is Thursday, April 19th. This is an increase from Zotefoams's previous dividend of $1.91. The official announcement can be seen at this link. View Zotefoams' Dividend History.

What price target have analysts set for ZTF?

3 brokers have issued 12 month price targets for Zotefoams' shares. Their forecasts range from GBX 575 to GBX 620. On average, they anticipate Zotefoams' stock price to reach GBX 597.50 in the next twelve months. This suggests a possible upside of 12.3% from the stock's current price. View Analyst Ratings for Zotefoams.

What is the consensus analysts' recommendation for Zotefoams?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zotefoams in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Zotefoams' key competitors?

Who are Zotefoams' key executives?

Zotefoams' management team includes the folowing people:
  • Mr. David B. Stirling BSC CA, MBA,MSC, Group Chief Exec. Officer, Managing Director and Director (Age 51)
  • Mr. Gary C. McGrath, Group CFO & Director
  • James W. Kindell, Company Sec.
  • Sara Hollowell, Interim Company Sec.

Has Zotefoams been receiving favorable news coverage?

News coverage about ZTF stock has been trending positive recently, according to Accern. The research firm rates the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Zotefoams earned a media sentiment score of 0.26 on Accern's scale. They also assigned news stories about the company an impact score of 48.56 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

How do I buy shares of Zotefoams?

Shares of ZTF and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Zotefoams' stock price today?

One share of ZTF stock can currently be purchased for approximately GBX 532.

How big of a company is Zotefoams?

Zotefoams has a market capitalization of £229.13 million.

How can I contact Zotefoams?

Zotefoams' mailing address is 675 Mitcham Road, CROYDON, CR9 3AL, United Kingdom. The company can be reached via phone at +44-20-86641600.


MarketBeat Community Rating for Zotefoams (LON ZTF)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  136 (Vote Outperform)
Underperform Votes:  132 (Vote Underperform)
Total Votes:  268
MarketBeat's community ratings are surveys of what our community members think about Zotefoams and other stocks. Vote "Outperform" if you believe ZTF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZTF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.